Vimarsana.com

Latest Breaking News On - Limmatech biologics - Page 1 : vimarsana.com

Vaccines in Development

Vaccines in Development
genengnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from genengnews.com Daily Mail and Mail on Sunday newspapers.

Austria
Chile
Switzerland
India
Oswaldo-cruz
Rio-grande-do-sul
Brazil
Australia
Denmark
United-states
Sweden
Santiago

LimmaTech Biologics Reports Positive Interim Phase I/II Clinical Data on Tetravalent Shigella Bioconjugate Vaccine S4V

SCHLIEREN, Switzerland, February 22, 2024--LimmaTech Biologics AG announced positive interim data from its Phase I/II clinical trial evaluating Shigella4V (S4V), a tetravalent bioconjugate vaccine candidate against shigellosis, an infectious disease caused by Shigella bacteria. Shigellosis is a serious infection and remains the second leading cause of fatal diarrheal disease, particularly in infants in low- and middle-income countries. In the nine-month-old target population, administration of S

Kenya
United-kingdom
Switzerland
Limmatech-biologics
Alexander-siebert
Patricia-martin
Franz-werner-haas
Network-meeting
Trophic-communications
Wellcome
Chief-operating-officer
Annual-network-meeting

Listeria Monocytogenes Infections Treatment Global Market Report 2024: Global Expansion In Listeria Monocytogenes Treatment Sector Predicted Amid Risi...

Listeria Monocytogenes Infections Treatment Global Market Report 2024: Global Expansion In Listeria Monocytogenes Treatment Sector Predicted Amid Risi...
menafn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from menafn.com Daily Mail and Mail on Sunday newspapers.

Dublin
Ireland
United-states
America
Bristol-myers-squibb
Laura-wood
Aurobindo-pharma
Fresenius-kabi
Limmatech-biologics
Eli-lilly
Glaxosmithkline
Regeneron-pharmaceuticals-inc

Antimicrobial Resistance Multiple Threats, Multiple Responses

Antimicrobial Resistance Multiple Threats, Multiple Responses
genengnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from genengnews.com Daily Mail and Mail on Sunday newspapers.

Kenya
Helsinki
Eteläuomen-läi
Finland
Greece
Finnish
Kenyan
Greek
Patricia-martin
Paul-garofolo
Lyndsay-meyer
Sam-sihvonen

LimmaTech Biologics Adds Additional $3 Million in Series A Second Closing Bringing Total Raised to $40 Million

LimmaTech Biologics Adds Additional $3 Million in Series A Second Closing Bringing Total Raised to $40 Million
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

Australia
Australian
Franz-werner-haas
Paul-wolfrom
Alexander-siebert
Nicola-forrest
Limmatech-biologics
Steve-burnell
Stefan-klotter
Trophic-communications
Impact-fund
Novo-holdings

LimmaTech Biologics Raises Additional $3M in Series A

FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!

Switzerland
Limmatech-biologics
Franz-werner-haas
Novo-holdings
Impact-fund
Adjuvant-capital

LimmaTech Biologics Expands Vaccine Pipeline by Licensing AbVacc's Innovative Vaccine Candidate Against Staphylococcus aureus

LimmaTech Biologics Expands Vaccine Pipeline by Licensing AbVacc's Innovative Vaccine Candidate Against Staphylococcus aureus
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United-kingdom
Germany
Sudan
Gretchen-schweitzer
Javad-aman
Franz-werner-haas
Limmatech-biologics
Michael-kowarik
National-institutes-of-health
Biomedical-advanced-research
Development-authority
Impact-fund

Vaccine profiles: Shigella

Reports of dysentery go back to ancient times, however it was only in the 19th Century that we discovered the bacteria behind it: Shigella. New vaccines on the horizon could have a huge impact in the lower-income countries where this deadly disease predominantly thrives.

Japan
Switzerland
Greece
Japanese
Swiss
Greek
Kiyoshi-shiga
Limmatech-biologics
Vaccine-alliance
World-health-organization
Century-japan
Ancient-greek

vimarsana © 2020. All Rights Reserved.